GeneOne Life Science, Inc.
KSC: 011000.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Young-Keun Park
- Employees
- 46
- Headquarters
- Seoul, South Korea
- IPO year
- 2000
- Market cap
- ₩102.4B
- Website
- https://www.genels.com
Loading 011000…
Loading profile data…Frequently asked questions about 011000
What does GeneOne Life Science, Inc. (011000.KS) do?
GeneOne Life Science, Inc., a biopharmaceutical company, engages in the development and contract manufacturing of gene-based-biomedicines. Its products comprise GLS-1027, which is in Phase I clinical trial for treatment of nephropathy and inflammatory diseases; GLS-1200 that is in Phase II clinical trial to treat Rhinosinusitis; GLS-1027 and GLS...
Where does 011000.KS trade?
GeneOne Life Science, Inc. (011000.KS) trades on the Korea Exchange.
What sector is 011000.KS in?
GeneOne Life Science, Inc. (011000.KS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of GeneOne Life Science, Inc.?
Young-Keun Park is the chief executive officer of GeneOne Life Science, Inc. (011000.KS).
Where is GeneOne Life Science, Inc. headquartered?
GeneOne Life Science, Inc. is headquartered in South Korea.
Does 011000.KS pay a dividend?
GeneOne Life Science, Inc. (011000.KS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 011000.KS go public?
GeneOne Life Science, Inc. (011000.KS) completed its initial public offering in 2000.